Organization
NeuroVive Pharmaceutical AB
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
NeuroVive Pharmaceutical AB
... Successful rights issue Business operations Important events January - March 2018 NeuroVive decided to conduct a rights issue for the continued development of the ...
... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South ...
... Lund - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced a partnership with TRACK-TBI, ...
... Lund - NeuroVive Pharmaceutical AB (publ) ('NeuroVive' or the 'Company') (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the outcome ...
... Lund - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ('NeuroVive') today on 27 April 2018 held its Annual General Meeting (AGM). A ...
... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced a partnership with TRACK-TBI, ...
... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) ("NeuroVive") today on 27 April 2018 ...
... In the current rights issue in NeuroVive, the Board, Senior Executives and employees have undertaken to subscribe for at ...
... ('Tillaggsprospekt') for the prospectus regarding the offer to subscribe for Units in NeuroVive, published on 9 April 2018. www.fi.se, on the Stockholm Corporate Finance AB ...
Subscribe now for full coverage on NeuroVive Pharmaceutical AB
Start My Free Trial